Appian Corp
NASDAQ:APPN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Appian Corp
Cash Equivalents
Appian Corp
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Appian Corp
NASDAQ:APPN
|
Cash Equivalents
$170.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Oracle Corp
NYSE:ORCL
|
Cash Equivalents
$9.5B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-6%
|
|
ServiceNow Inc
NYSE:NOW
|
Cash Equivalents
$2.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
26%
|
CAGR 10-Years
20%
|
|
Palo Alto Networks Inc
NASDAQ:PANW
|
Cash Equivalents
$1.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
19%
|
|
Microsoft Corp
NASDAQ:MSFT
|
Cash Equivalents
$19.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
5%
|
|
CrowdStrike Holdings Inc
NASDAQ:CRWD
|
Cash Equivalents
$3.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
109%
|
CAGR 10-Years
N/A
|
See Also
What is Appian Corp's Cash Equivalents?
Cash Equivalents
170.1m
USD
Based on the financial report for Mar 31, 2024, Appian Corp's Cash Equivalents amounts to 170.1m USD.
What is Appian Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
18%
Over the last year, the Cash Equivalents growth was -14%. The average annual Cash Equivalents growth rates for Appian Corp have been 14% over the past three years , 18% over the past five years .